Hereditary factors and syndromes of genetic predisposition related to sarcomas of soft parts
Keywords:
malignancy, sarcoma of soft parts, hereditary disease, genetic disorder, syndrome of genetic predisposition.Abstract
The sarcomas of soft parts are malignancies that originate in the connective tissue, starting from the embryonic mesenchyme. Taking into account the existence of new and constant changes in the nature of these tumors, a review of the most recent publications was carried out to deepen in the genetic disorders, the predisposing syndromes and its relationship with sarcomas. It was concluded that the records that describe the identification of these syndromes are still very few as main link in the development of sarcomas.
Downloads
References
2. Galy Bernadoy, Garrel R . Head and neck soft-tissue sarcoma in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2016 [citado 22/01/2021];133(1):37-42. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26403655/
3. Kazuhiro T, Toshifumi O. New TNM classification (AJCC eighth edition) of bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group. Jpn J Clin Oncol. 2019 [citado 22/01/2021]; 49(2). Disponible en: https://academic.oup.com/jjco/article/49/2/103/5179391
4. Ray Coquard I, Serre D, Reichardt P, Martín Broto J, Bauer S. Options for treating different soft tissue sarcoma subtypes. Future Oncol. 2018 [citado 22/01/2021]; 14(10):25-49. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29768052/
5. Ventura Martínez N, Cebreros Rosas D, Miragall Alba L, Ruiz Gutierrez JP, Puglia-Santos V. Sarcoma de Ewing extraóseo en cabeza y cuello: revisión de la literatura a propósito de un caso. Rev Esp Cir Oral Maxilo Fac. 2017 [citado 22/01/2021]; 39(2):105–12. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-05582017000200105
6. Arranz J, Patricia F, Díaz A. Guía oncosur de sarcomas de partes blandas. Madrid: Fundación OncoSur; 2017 [citado 22/01/2021]. Disponible en: https://congresos.grupoaran.com/guia-oncosur-sarcomas/files/assets/basic-html/page-1.html
7. Siegel R, Miller K, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016 [citado 22/01/2021];66(1):7-30. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26742998/
8. Chávez M, Ziegler G, Cotrina J, Galarreta J, Cruz M de la, Mantilla R. Current situation of soft tissue sarcomas: Registry of a Latin American Cancer Institute. Cir Española. 2019 [citado 22/01/2021];97(4):203-12. Disponible en: https://www.elsevier.es/en-revista-cirugia-espanola-english-edition--436-articulo-current-situation-soft-tissue-sarcomas-S2173507719300742
9. Mahajan A, Mohanty S, Ghosh S, Aadithya B. Urs A, Sunita G. Sarcomatoid carcinoma of the oral cavity: a diagnostic dilemma. Case Reports in Dentistry. 2017 [citado 22/01/2021] Article ID 7495695. Disponible en: https://www.hindawi.com/journals/crid/2017/7495695/
10. Pérez Huitrón MA, Domínguez Castillo PM. El retinoblastoma: un tumor de ojo frecuente en la infancia. Rev. Fac. Med. (Méx.). 2019 [citado 22/01/2021]; 62(4). Disponible en: https://downloads.hindawi.com/journals/crid/2017/7495695.pdf
11. Dimaras H, Corson TW. Retinoblastoma, the visible CNS tumor: a review. J Neurosci Res. 2019 [citado 22/01/2021];97(1):29-44. https://pubmed.ncbi.nlm.nih.gov/29314142/
12. Czarnecka AM, Synoradzki K, Firlej W, Bartnik E, Sobczuk P, Fiedorowicz M, et al. Molecular biology of osteosarcoma. Cancers (Basel). 2020 [citado 22/01/2021]; 12(8):2130. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32751922/
13. Miranda Alcalde B, Villa Alcázar M, Martínez Romera I, López Ibor B. Importancia del síndrome de Li-Fraumeni, un síndrome genético de predisposición al cáncer. Arch Argent Pediatr. 2021 [citado 22/01/2021];119(1):e11-e7. Disponible en: https://www.sap.org.ar/docs/publicaciones/archivosarg/2021/v119n1a16.pdf
14. Rodríguez Jiménez P, Reolid A, Chicharro P, Navarro R, Llamas Velasco M, Aragüés M. Treatment and prognosis of angiosarcoma: experience with 12 patients and review of new therapeutic lines. Med Cutan Iber Lat Am. 2017 [citado 22/01/2021]; 45(2): 112-18. Disponible en: https://www.medigraphic.com/pdfs/cutanea/mc-2017/mc172e.pdf
15. Sánchez Forero RA, Jaramillo LF, Ramírez J. Angiosarcoma cutáneo en la región nasal tratado con radioterapia: reporte de caso. Univ. Med. Colombia. 2018 [citado 22/01/2021];59(3). Disponible en: http://www.scielo.org.co/pdf/unmed/v59n3/0041-9095-unmed-59-03-00094.pdf
16. Camejo N, Castillo C, Richter L, Massia MN, Artagaveytia N, Neffa F, et al. Síndrome de Li Fraumeni: análisis clínico de un caso y revisión de la literatura Rev. Urug. Med. Int. 2018 [citado 22/01/2021];3:20-6. Disponible en: http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S2393-67972018000300020
17. Ossa CA, Molina G, Cock Rada AM. Síndrome de Li-Fraumeni. Biomédica. 2016 [citado 22/01/2021];36:182. Disponible en: http://www.scielo.org.co/pdf/bio/v36n2/v36n2a04.pdf
18. Miranda Alcaldea B, Villa Alcázara M, Martínez Romera I, López Ibo B. The importance of Li-Fraumeni syndrome, a hereditary cancer predisposition disorder. Arch Argent Pediatr. 2021 [citado 22/01/2021];119(1):11-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33458985/
19. Adil A, Koritala T, Singh A. Neurofibromatosis Type 1. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021 [citado 22/01/2021]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK459358/
20. Hameed M, Mandelker D. Tumor syndromes predisposing to osteosarcoma. Adv Anat Pathol. 2018 [citado 22/01/2021];25(4):217-22. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29668499/
21. Duat Rodríguez A. Neurofibromatosis tipo 1. Pediatr Integral. 2020 [citado 22/01/2021]; 24(6): 334-41. Disponible en: https://www.pediatriaintegral.es/publicacion-2020-09/neurofibromatosis-tipo-1/
22. Martinez AP, Fritchie KJ. Update on Peripheral Nerve Sheath Tumors. Surg Pathol Clin. 2019 [citado 22/01/2021];12(1):1-19. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30709438/
23. Charifa A, Jamil RT, Zhang X. Gardner Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021 [citado 22/01/2021]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29493967/
24. Maita F, Mamani Vidal CA, Morales Reinaga LA, Arnés Terrazas R, Sánchez Soria Galvarro K. Complejo esclerosis tuberosa: diagnóstico, manejo pre y posnatal: reporte de un caso clínico. Gac Med Bol. 2017 [citado 22/01/2021]; 40(1): 41-5. Disponible en: http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1012-29662017000100009
25. Gómez Cerdas MT, Vargas Morales JA. Esclerosis tuberosa. Rev Méd Sinerg. 2019 [citado 22/01/2021];4(3):21. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/182
26. Ballesteros Zárate ZY, Pardo Heredia AE, Martínez Martínez JS. Tuberous Sclerosis Complex, Main Characteristics and Cutaneous Manifestations. A Pediatric case. Dermatol Cosmética Méd Quir. 2019 [citado 22/01/2021];17(3):179-83. Disponible en: https://www.medigraphic.com/pdfs/cosmetica/dcm-2019/dcm193e.pdf
27. Hafsi W, Badri T. Poikiloderma Congenitale. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020 [citado 22/01/2021]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK526123/
28. Schaefer IM, Hornick JL. Diagnostic Immunohistochemistry for Soft Tissue and Bone Tumors: An Update. Adv Anat Pathol. 2018 [citado 22/01/2021];25(6):400-12. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30134255/
29. Mukherjee S, Sinha D, Bhattacharya S, Srinivasan K, Abdisalaam S, Asaithamby A. Werner Syndrome protein and DNA replication. Int J Mol Sci. 2018 [citado 22/01/2021];19(11):3442. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30400178/
30. De Renty C, Ellis NA. Bloom's syndrome: why not premature aging? A comparison of the BLM and WRN helicases. Ageing Res Rev. 2017 [citado 22/01/2021];33:36-51. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27238185/
31. Acosta Aragón M, Sierra Zúñiga MF, Sotelo Muñoz NF. Síndrome de Werner a propósito de un caso probable. Medicina y laboratorio. 2017 [citado 22/01/2021];23(9-10):485-92. Disponible en: https://medicinaylaboratorio.com/index.php/myl/article/view/27
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.